0001699493-19-000001.txt : 20190418 0001699493-19-000001.hdr.sgml : 20190418 20190418111013 ACCESSION NUMBER: 0001699493-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190418 DATE AS OF CHANGE: 20190418 EFFECTIVENESS DATE: 20190418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arrakis Therapeutics, Inc. CENTRAL INDEX KEY: 0001699493 IRS NUMBER: 475064524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-337635 FILM NUMBER: 19755028 BUSINESS ADDRESS: STREET 1: 210 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-488-4488 MAIL ADDRESS: STREET 1: 210 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001699493 Arrakis Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 857-488-4488 DELAWARE None None Corporation true 2015 Michael Gilman c/o Arrakis Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Executive Officer Director Raj Parekh c/o Arrakis Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Colleen Cuffaro c/o Arrakis Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Nikola Trbovic c/o Arrakis Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Richard Gaster c/o Arrakis Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Jakob Loven c/o Arrakis Therapeutics, Inc. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2019-04-15 true true false 0 74999986 14999992 59999994 false 15 0 0 0 false Arrakis Therapeutics, Inc. /s/Michael Gilman Michael Gilman President 2019-04-18